YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Organogenesis Holdings President, Chief Executive Officer, and Chair of the Board - Gary S. Gillheeney, Sr. Chief Financial Officer - David Franci…
CANTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacture, and sale of pro…
CANTON, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacturing, and sale of p…
(RTTNews) - Organogenesis Holdings Inc. (ORGO) announced that the U.S. FDA has accepted its Biologics License Application (BLA) for ReNu, a cryopreserved amniotic suspension allograft designed to manage pain in patients with symptomatic kn…
Issued on behalf of Conexeu Sciences Inc. A sector analysis of regenerative medicine — the science of restoring tissue rather than merely replacing it — and where a new generation of platform companies is trying to fit in. NEW YORK, June 1…
We recently compiled a list of the 8 Best Small Cap Pharma Stocks to Buy Right Now. Organogenesis Holdings Inc. (NASDAQ:ORGO) is one of the best pharmaceutical stocks on our list. TheFly reported on May 8 that BTIG downgraded ORGO to Neutr…
Image source: The Motley Fool. DATE Thursday, May 7, 2026 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Gary S. Gillheeney Chief Financial Officer — David Francisco Full Conference Call Transcript Gary Gillheeney: Thank you, ope…
Earnings Call Insights: Organogenesis Holdings (ORGO) Q1 2026 MANAGEMENT VIEW * "Net revenue declined 58% year-over-year, driven by a 63% decline in sales of our Advanced Wound Care products" (President, CEO, Chair of the Board Gary Gillhe…
* Organogenesis Holdings press release [https://seekingalpha.com/pr/20506842-organogenesis-holdings-inc-reports-first-quarter-2026-financial-results] (ORGO [https://seekingalpha.com/symbol/ORGO]): Q1 GAAP EPS of -$0.44 misses by $0.13. * R…
The market has shown robust performance, rising 3.1% over the last week and 27% over the past year, with earnings expected to grow by 16% annually in the coming years. In light of these conditions, identifying stocks with solid financials…
(RTTNews) - Organogenesis Holdings Inc. (ORGO) announced it has completed a randomized controlled trial evaluating PuraPly AM in the management of non-healing diabetic foot ulcers. The randomized controlled trial (RCT) of PuraPly AM plus s…
Statistically significant (p<0.0477) DFU wound closure at 12 weeksRCT compared PuraPly®AM plus standard of care to standard of care aloneResults strengthen existing clinical evidence supporting future coverage CANTON, Mass., April 06, 2026…
Clinical Development Program Appropriate for Rolling BLA Submission Expected by the End of 2025 CANTON, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused o…
CANTON, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacturing, and sale of…
Organogenesis logo Key Points Organogenesis reported record Q4 results, with net product revenue of $225.1 million (up 78% YoY) driven by an 83% YoY increase in advanced wound care sales to $217.2 million, surpassing prior guidance. For 20…
Earnings Call Insights: Organogenesis Holdings Inc. (ORGO) Q4 2025 MANAGEMENT VIEW * CEO Gary Gillheeney highlighted record sales in the fourth quarter, stating the company "delivered record sales results, which exceeded the high end of th…
NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO). Such investors are advised to contact Danielle Peyto…
[CMS] gustavofrazao Organogenesis (ORGO [https://seekingalpha.com/symbol/ORGO]) and MiMedx (MDXG [https://seekingalpha.com/symbol/MDXG]) traded lower on Friday after the Centers for Medicare & Medicaid Services (CMS) announced the withdraw…
[Mild osteoarthritis on the knee joint - 3D Rendering] CreVis2/iStock via Getty Images * Organogenesis (ORGO [https://seekingalpha.com/symbol/ORGO]) said it has begun a rolling BLA submission for ReNu, its cryopreserved, amniotic suspensio…
[Stock Market] sweetym/iStock via Getty Images U.S. stock futures retreated Tuesday as investors adopted a cautious stance ahead of November’s employment data, a key indicator for the labor market’s health. Here are some of Tuesday's bigge…
(RTTNews) - A cluster of healthcare and med-tech stocks posted notable strength in Monday's after-hours session, driven by regulatory progress, clinical-data visibility, and merger-related developments, with a few quiet movers adding to th…
Clinical Development Program Appropriate for Rolling BLA Submission Expected by the End of 2025 CANTON, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on…
As the United States market experiences fluctuations, with technology shares weighing on major indices like the Nasdaq, investors are closely monitoring economic indicators and Federal Reserve actions. In this context, penny stocks—often s…
(RTTNews) - A wave of earnings releases and revised 2025 guidance triggered strong after-hours gains across several healthcare and life sciences stocks on Thursday. Globus Medical (GMED) surged 24.37% to $76.75 after hours, following a thi…
As the United States stock market reaches record highs, driven by a tame inflation report and expectations of an interest rate cut, investors are exploring diverse opportunities across various sectors. Penny stocks, often associated with s…
In the current U.S. market landscape, major stock indices like the Dow Jones, S&P 500, and Nasdaq have shown modest gains as investors assess banking sector health and geopolitical developments. Amid this backdrop of cautious optimism, gro…
CANTON, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound…
[A senior Asian woman massaging her knee, suffering from pain in leg while sitting on sofa in the living room at home] Thai Liang Lim/iStock via Getty Images * Organogenesis (NASDAQ:ORGO [https://seekingalpha.com/symbol/ORGO]) said a secon…
Company maintains confidence in ReNu as innovative pain management therapy Second Phase 3 trial demonstrates numerical improvement in baseline pain reduction over the first Phase 3 trial despite not meeting the primary endpoint Statistical…
As the U.S. stock market navigates record highs with the Nasdaq and S&P 500 leading the charge, investors are keenly watching the Federal Reserve's upcoming interest rate decision amid ongoing trade negotiations between the U.S. and China.…
CANTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound…
With the recent surge in U.S. stock markets, driven by expectations of possible interest rate cuts, investors are increasingly exploring various opportunities to optimize their portfolios. Penny stocks, a term that often refers to smaller…
As of August 2025, the U.S. stock market is experiencing a surge, with the S&P 500 and Nasdaq reaching record highs following positive inflation data that has bolstered hopes for interest rate cuts by the Federal Reserve. In this thriving…
The United States market has shown positive momentum, rising 1.3% in the last week and 15% over the past year, with earnings expected to grow annually by 15%. While the term 'penny stock' may seem outdated, it still signifies opportunities…
[Man looking at currency trading app on his smart phone from his home office] Alistair Berg Stock futures edged higher early Tuesday as investors awaited the kickoff of earnings season, with major banks JPMorgan (JPM), Citigroup (C), and W…
[Centers For Medicare And Medicaid Services Headquarters] A proposed payment rule unveiled Monday by CMS aims to reduce unnecessary spending and boost quality measures, as well as launch a new payment model centered on chronic disease mana…